1,7-Diazaspiro[4.4]nonan-2-one 2,2,2-trifluoroacetate

Catalog No. :
ACHSFN415
CAS No. :
1566649-47-5
Molecular Formula :
C9H13F3N2O3
Molecular Weight :
254.21

IUPAC Name:1,7-diazaspiro[4.4]nonan-2-one 2,2,2-trifluoroacetate

1,7-Diazaspiro[4.4]nonan-2-one 2,2,2-trifluoroacetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$56.00Login to see priceIn stockInquiry
250mg98%$138.00Login to see priceIn stockInquiry
1g98%$548.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,7-Diazaspiro[4.4]nonan-2-one 2,2,2-trifluoroacetate
IUPAC Name1,7-diazaspiro[4.4]nonan-2-one 2,2,2-trifluoroacetate
MDL No.MFCD27987091
Molecular FormulaC9H13F3N2O3
Molecular Weight254.21
SMILESO=C1NC2(CNCC2)CC1.O=C(O)C(F)(F)F
InChI KeyVXBWFTBSMZXDLJ-UHFFFAOYSA-N
Synonym1566649-47-5 | 1,7-Diazaspiro[4.4]nonan-2-one 2,2,2-trifluoroacetate | 1,7-diazaspiro[4.4]nonan-2-one; trifluoroacetic acid | 1,7-Diazaspiro[4.4]nonan-2-one tfa | 1,7-diazaspiro[4.4]nonan-2-one trifluoroacetate | MFCD27987091 | 1,7-diazaspiro[4.4]nonan-2-one;2,2,2-tr
CAS No.1566649-47-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACHSFN415 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHSFN415 route product structure diagram
    ACHSFN4151566649-47-5 In Stock
Inquiry

2. ACHSFN415 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACJCDX218 route compound structure diagram
    ACJCDX2181160246-72-9 In Stock
  2. Then
  3. ACHSFN415 route product structure diagram
    ACHSFN4151566649-47-5 In Stock
Inquiry

Comments (0)